Enjoy complimentary customisation on priority with our Enterprise License!
Technavio’s market research analyst has estimated the global market for liver diseases therapeutics to grow rapidly during the forecast period. Factors like the increased prevalence of liver cancer in developed countries and the expected entry of pipeline drugs into the market are expected to result in this market’s impressive CAGR of more than 15% by 2019.
The high-unmet medical need of the populace is a key driver for the growth of this market. Drugs that are currently available in this market have adverse side effects and, therefore, results in increased noncompliance among individuals with liver diseases. Additionally, since the availability of hepatitis vaccine is low in many regions, the medical needs of the populace remains unmet for extended periods of time.
Get lifetime access to our
Technavio Insights
Quick Report Overview:
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.
Get the report (PDF) sent to your email within minutes.